The MarketWatch News Department was not involved in the creation of this content. -- Enrollment complete in the replicate REDUCE 1 and REDUCE 2 Phase 3 studies with pivotal data expected in Q2 2026 ...
Indication(s): Chronic gout in adult patients refractory to conventional therapy. The expanded approval was based on data from the phase 4 MIRROR trial, which evaluated Krystexxa plus methotrexate in ...
Gout is a painful inflammatory condition that is associated with overindulgence of foods like red meat, shellfish, and alcohol. In medieval times, gout was associated with nobility because of the cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results